CLINICAL TRIAL

Treatment for Osteoporosis, Age Related

Recruiting · 18+ · All Sexes · Lexington, KY

Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover

See full description

About the trial for Osteoporosis, Age Related

Eligible Conditions
Osteoporosis, Age Related · Osteoporosis

Treatment Groups

This trial involves 3 different treatments. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 4 and have been shown to be safe and effective in humans.

Control Group 1
Teriparatide
DRUG
Control Group 2
Alendronate
DRUG
Control Group 3
Alendronate
DRUG

Eligibility

This trial is for patients born any sex aged 18 and older. There are 6 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
The person has been diagnosed with osteoporosis by means of a DXA scan (a scan that measures bone mineral density) which showed that their bone mineral density was less than 2.5 standard deviations below the average for their sex and age show original
Age ≥ 40 years;
Females;
oys The absence of alloys means that pure metals are used show original
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 1 Year
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 1 Year.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 2 primary outcomes in patients with Osteoporosis, Age Related. Measurement will happen over the course of 1 Year.

Mineral Bone Density of the lumbar spine
1 YEAR
Percent change in mineral bone density absolute values of the lumbar spine measured by DXA at baseline and at one year.
Measure of serum osteocalcin levels to predict bone turnover
1 YEAR
Diagnostic Utility of serum osteocalcin level measurements by ELISA at baseline and at one year to predict bone turnover. Area under the receiver operating characteristic curve analysis will be used to determine the discriminative power of osteocalcin levels for determination of low versus non-low bone turnover.

Patient Q & A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Osteoporosis, Age Related by sharing your contact details with the study coordinator.